OSCAR ENDO One Stop Assessment of Risk for Endometrial Hyperplasia and Cancer
|Endometrial Cancer Atypical Hyperplasia||Procedure: hysteroscopy/curettage in case of suspicious aspect will be done a rapid section|
|Study Design:||Observational Model: Case-Only|
|Official Title:||Pilot-study of OSCAR ENDO One Stop Assessment of Risk for Endometrial Hyperplasia and Cancer|
- A negative predictive value of 99 % [ Time Frame: Intraoperative ]To get in combination of hysteroscopy and rapid section of the endometrial curettement a negative predictive value of 99% as well as a positive predictive value of 100%.
|Study Start Date:||May 2013|
|Study Completion Date:||March 2016|
|Primary Completion Date:||September 2015 (Final data collection date for primary outcome measure)|
Procedure: hysteroscopy/curettage in case of suspicious aspect will be done a rapid section
If a patient fulfills the inclusion criteria, the surgeon decides intraoperatively due to the aspect in the hysteroscopy if it is a clearly benign result or if it looks suspicious or malign.
In case of a hysteroscopical benign result the patient will be informed about the result after the operation.
In case of a hysteroscopal suspicious or malignant aspect, the curettement will be sent for a rapid section. If the hysteroscopic result confirms the hysteroscopic suspicion the patient will be informed after the operation and the further treatment can be planned right away.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01961102
|Department of Gynaecology, Barmherzige Schwestern|
|Linz, Austria, 4020|